Nurse Practitioner, Family · Coram, NY
NPI
1548456197
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
82 Middle Country Rd
Coram, NY, 11727
Phone (631) 320-2220
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
147 services
Medicare patients, 2024
49
Average age 66
Drug cost, 2024
$4.2M
2,870 prescriptions
Company payments, 2025
$132
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marina I Guzman was code 99214 (office e&m - established), 42 times for 25 patients. In total Marina I Guzman billed 147 services in 25 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 42 | 25 | $77.43 | $3,252 |
| 99215 Office E&M - Established | Office | 23 | 17 | $121.42 | $2,793 |
By year: 2022 $23K for 775 services; 2023 $12K for 166 services; 2024 $11K for 147 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marina I Guzman prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 345 prescriptions and refills. In total Marina I Guzman wrote 2,870 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 345 | 377 | 50 | $1.4M |
| Atorvastatin Calcium Generic | 250 | 392 | 52 | $825 |
| Tivicay Dolutegravir Sodium | 147 | 151 | 19 | $371K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 130 | 150 | 15 | $564K |
| Juluca Dolutegravir/Rilpivirine | 120 | 120 | 14 | $407K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 88 | 90 | Under 11 | $310K |
| Descovy Emtricitabine/Tenofov Alafenam | 88 | 104 | 12 | $223K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 72 | 72 | 12 | $2,374 |
| Amlodipine Besylate Generic | 57 | 81 | 11 | $128 |
| Hydrochlorothiazide Generic | 54 | 84 | Under 11 | $65.36 |
| Gabapentin Generic | 53 | 59 | Under 11 | $290 |
| Omeprazole Generic | 51 | 57 | Under 11 | $97.3 |
| Losartan Potassium Generic | 50 | 68 | Under 11 | $177 |
| Famotidine Generic | 49 | 65 | Under 11 | $261 |
| Valacyclovir Valacyclovir Hcl | 49 | 59 | Under 11 | $1,212 |
Brand drugs: - claims; generic drugs: 1,605 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marina I Guzman $132 ($132 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $132.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.